Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford GlycoSciences
Oxford, England, United Kingdomwww2.bioch.ox.ac.uk ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Oxford GlycoSciences developed a proteomics platform and brought Zavesca (miglustat), a treatment for Gaucher disease, to market. The company also established collaborations with multinational pharmaceutical companies. It was acquired by Celltech in 2003 after a competitive bidding process involving several biotech firms. At the time of acquisition, its main commercial product was Zavesca, and it had ongoing research programs in proteomics and cancer targets[2][3][8].
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Proteomics-based drug discoverysmall moleculesbiologicsglycobiology
- Industry
- Biotech
02
Partnerships
Collaborations with several multinational pharmaceutical companies for proteomics applicationsActelion discussed as potential partner/licensee for rights to Zavesca after Celltech’s acquisition
Beyond the preview
Go deeper on Oxford GlycoSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxford GlycoSciences.